WFDC10B: A Potential Drug Target and Biomarker (G280664)
WFDC10B: A Potential Drug Target and Biomarker
WFDC10B (WFDC10B variant 2) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the WFDC (Wnt-Factor D) family, which is known for its role in the development and maintenance of tissues during embryonic development.
WFDC10B is involved in several physiological processes in the body, including cell adhesion, migration, and signaling. It has been shown to play a role in the development and maintenance of the nervous system, and is often used as a drug target or biomarker for several diseases.
One of the most promising aspects of WFDC10B is its potential as a drug target. WFDC10B has been shown to interact with several protein molecules, including the neurotransmitter GABA. GABA is a well-known inhibitory neurotransmitter that has been shown to have a range of therapeutic potential, including the treatment of anxiety, depression, and PTSD.
WFDC10B has also been shown to interact with the protein PDGF-BB, which is a potent regulator of cell growth and differentiation. PDGF-BB has been shown to play a role in the development and maintenance of tissues during embryonic development, and is often used as a drug target for several diseases, including cancer.
Another promising aspect of WFDC10B is its potential as a biomarker. WFDC10B has been shown to be expressed in a variety of tissues and cells, including brain, heart, and kidney cells. It has been shown to have a stable expression level and can be used as a protein biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.
In addition to its potential as a drug target or biomarker, WFDC10B is also of interest as a potential therapeutic agent. Studies have shown that WFDC10B can be expressed and purified from human placenta, and that it has been shown to be effective in animal models of several diseases, including cancer.
Overall, WFDC10B is a protein that has the potential to be a drug target or biomarker for several diseases. Further research is needed to fully understand its role and its potential as a therapeutic agent.
Protein Name: WAP Four-disulfide Core Domain 10B
More Common Targets
WFDC11 | WFDC12 | WFDC13 | WFDC2 | WFDC21P | WFDC3 | WFDC5 | WFDC6 | WFDC8 | WFDC9 | WFIKKN1 | WFIKKN2 | WFS1 | WHAMM | WHAMMP1 | WHAMMP2 | WHAMMP3 | WHRN | WIF1 | WIPF1 | WIPF2 | WIPF3 | WIPI1 | WIPI2 | WIZ | WLS | WNK1 | WNK2 | WNK3 | WNK4 | Wnt | WNT1 | WNT10A | WNT10B | WNT11 | WNT16 | WNT2 | WNT2B | WNT3 | WNT3A | WNT4 | WNT5A | WNT5B | WNT6 | WNT7A | WNT7B | WNT8A | WNT8B | WNT9A | WNT9B | WRAP53 | WRAP73 | WRN | WRNIP1 | WSB1 | WSB2 | WSCD1 | WSCD2 | WSPAR | WT1 | WT1-AS | WTAP | WTAPP1 | WTIP | WWC1 | WWC2 | WWC2-AS2 | WWC3 | WWOX | WWP1 | WWP2 | WWTR1 | WWTR1-AS1 | XAB2 | XACT | XAF1 | XAGE-4 | XAGE1A | XAGE1B | XAGE1D | XAGE2 | XAGE3 | XAGE5 | XBP1 | XCL1 | XCL2 | XCR1 | XDH | XG | XGY2 | XIAP | XIRP1 | XIRP2 | XIST | XK | XKR3 | XKR4 | XKR5 | XKR6 | XKR7